Novel Biologics for Castration-Resistant Prostate Cancer
Sipuleucel-T and abiraterone acetate are two of the newest therapeutic options available to patients, but other promising agents are on the horizon.
Sipuleucel-T and abiraterone acetate are two of the newest therapeutic options available to patients, but other promising agents are on the horizon.